NECLIFE.NS
Nectar Lifesciences Limited$11.98
Jun 05, 2026
Market cap
$2.69B
52w range
—
P / E
—
EPS · FY 2026
$-14.57
Volume
—
Revenue · FY 2026
$0
Explain this page
Arphra AIPlain-English read on Nectar Lifesciences Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Communication Services+0.40%
- Financial Services+0.18%
- Energy+0.01%
- Technology-0.07%
- Consumer Cyclical-0.13%
- Consumer Defensive-0.45%
- Healthcare-0.50%
- Industrials-0.73%
- Basic Materials-1.36%
- Utilities-1.53%
- Real Estate-1.58%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-0.44%
- Electronic Gaming & Multimedia+3.97%
- Investment - Banking & Investment Services-2.87%
- Financial - Mortgages+2.35%
- Furnishings, Fixtures & Appliances+2.05%
- Coal-1.99%
- Chemicals-1.98%
- Solar-1.95%
- Medical - Healthcare Information Services+1.92%
- Travel Services+1.69%
- Gambling, Resorts & Casinos+1.65%
- Apparel - Footwear & Accessories+1.57%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for NECLIFE.NS.
Peers
No peer list available for NECLIFE.NS.
Total assets
$6.22B
Total debt
$0
Cash & equiv
$1.12B
Operating CF
-$3.49B
Free cash flow
-$3.61B
Buybacks
-$810M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $0 | -$590.34M | -$2.93B | $-14.57 | — |